Ulisse Biomed S.p.A. (BIT:HLX)
Italy · Delayed Price · Currency is EUR 0.8080
+0.0020 (0.25%)
At close: Dec 15, 2025
Ulisse Biomed Revenue
Ulisse Biomed had revenue of 528.79K EUR in the half year ending June 30, 2025, with 3,176.49% growth. This brings the company's revenue in the last twelve months to 925.87K, up 119.96% year-over-year. In the year 2024, Ulisse Biomed had annual revenue of 767.93K with 1,059.87% growth.
Revenue (ttm)
925.87K
Revenue Growth
+119.96%
P/S Ratio
21.31
Revenue / Employee
51.44K
Employees
22
Market Cap
19.73M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 767.93K | 701.72K | 1,059.87% |
| Dec 31, 2023 | 66.21K | -72.23K | -52.17% |
| Dec 31, 2022 | 138.44K | -142.00K | -50.64% |
| Dec 31, 2021 | 280.44K | -325.06K | -53.68% |
| Dec 31, 2020 | 605.50K | 594.63K | 5,469.84% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Stellantis | 146.12B |
| Eni S.p.A. | 86.56B |
| Enel SpA | 77.78B |
| Assicurazioni Generali | 56.79B |
| Intesa Sanpaolo | 25.32B |
| UniCredit | 24.85B |
| Prysmian | 19.49B |
| Leonardo S.p.a. | 19.13B |